OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY

Published:2008-03 Issue:3 Volume:28 Page:S13-S18
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

LALWANI GEETA A.,BERROCAL AUDINA M.,MURRAY TIMOTHY G.,BUCH MARIA,CARDONE SCOTT,HESS DITTE,JOHNSON ROSE A.,PULIAFITO CARMEN A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference12 articles.

1. Current incidence of retinopathy of prematurity, 1989–1997.;Hussain;Pediatrics,1999

2. Pathogenesis of retinopathy of prematurity.;Smith;Acta Paediatr,2002

3. Oxygen-induced retinopathy in the rat: relationship of retinal perfusion to subsequent neovascularization.;Penn;Invest Ophthalmol Vis Sci,1994

4. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.;Alon;Nature Medicine,1995

5. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.;Lashkari;Am J Pathol,2000

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INCIDENCE AND RISK FACTORS FOR EXUDATIVE RETINAL DETACHMENT FOLLOWING LASER PHOTOCOAGULATION FOR RETINOPATHY OF PREMATURITY;Retina;2024-02

2. Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China;Frontiers in Medicine;2022-05-31

3. The Use of Bevacizumab in the Treatment of Retinopathy of Prematurity;International Ophthalmology Clinics;2021-12-29

4. PARADIGM SHIFT IN MANAGEMENT OF ROP: FROM LASERS TO ANTI-VEGF THERAPY;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2021-12-01

5. Treatment outcomes of combination of anti-vascular endothelial growth factor injection and laser photocoagulation in Type 1 ROP and APROP;International Ophthalmology;2021-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3